Latest filing published 14 Feb 2012 for Nextgen Healthcare, INC., €97k.
No signal scores available.
James J. Sullivan is a declared insider at 2 companies; the most frequent names are Trizetto Group Inc and Nextgen Healthcare, Inc. Over a trading history stretching from 15 February 2006 to 13 February 2012, the count stands at 24 filings.
Sales make up the whole of the open-market record (8 sales, €977k). Besides market trades, the filings include 8 share grants and 7 option exercises. In 2012 alone, the filings show no purchases and 1 sale.
On 14 February 2012 came the latest disclosure, an option exercise for €97k in Nextgen Healthcare, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations